Trial intelligence / Profile preview

Talampanel Effects on Cortical Excitability

NCT00057460Phase 2Completed

Sponsor
National Institute of Neurological Disorders and Stroke
Start
Apr 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of talampanel in epilepsy, sponsored by National Institute of Neurological Disorders and Stroke. Started Apr 2003; status: completed.

02

Drugs

talampanel
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT00057460.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00057460.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call